Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice
International Journal of Technology Assessment in Health Care, 04/17/09
Grishchenko M et al. - The study concludes that, based on cost and effectiveness data collected from routine clinical practice, treatment with pegylated interferon and ribavirin is generally cost-effective. The study shows that there are variations according to patient subgroup and for older (aged 50 or over) genotype 1 patients with cirrhosis, antiviral treatment appears less cost-effective.
Related Articles
APRI as a predictor of early viral response in chronic hepatitis C patients
World Journal of Gastroenterology, 10/26/09
Relevance Score: 82%
Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C
Alimentary Pharmacology and Therapeutics, 10/23/09
Relevance Score: 82%
Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial
Hepatology, 10/14/09
Relevance Score: 82%
Molecular mechanisms of insulin resistance in chronic hepatitis C
World Journal of Gastroenterology, 10/01/09
Relevance Score: 82%
Coffee good for chronic hepatitis C patients
Internet Source, 10/27/09
Relevance Score: 81%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin
Current Medical Research and Opinion, 12/11/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer
The Journal of Thoracic and Cardiovascular Surgery, 12/14/09
Medication Usage and the Risk of Neoplasia in Patients With Barretts Esophagus
Clinical Gastroenterology and Hepatology , 12/14/09
Sponsor
Article Search
Sponsor
Sponsor